KCND3 and movement disorder: More than 80 patients have been reported over time, broadening the clinical spectrum of KCND3 deficiency to include epilepsy, intellectual disability/cognitive impairment, movement disorders, pyramidal signs, and peripheral neuropathy [5,6,8,9,10,12,13,14,15,16,17,18,19,20].